The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share. The biotechnology company posted ...
News
- Milestone Pharmaceuticals: Q2 Earnings Snapshot
- Histogen: Q2 Earnings Snapshot
The biotechnology company posted revenue of $5,000 in the period. In the final minutes of trading on Wednesday, the company's shares hit 92 cents.
- Xenon Pharmaceuticals: Q2 Earnings Snapshot
The gene therapy biotech company posted revenue of $2.2 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks ...
- Former ski resort president reaches plea deal in fraud cause
A former Vermont ski resort president has reached a plea deal over a failed plan to build a biotechnology plant in Newport using tens of millions of ...
- The Latest: WHO to decide on authorizing Indian-made vaccine
... says the U.N. health agency's assessment of the Bharat Biotech vaccine was ... Meantime, a state district judge in San Antonio granted a temporary ...